Thus, any use of CTLA-4 or OX40 Abs as adjuvants for Env vaccination will have to be used transiently and it will be important to clearly demonstrate that, as used, there is no induction of manifestations of autoimmune disease. Here, TNFRSF4 is linked to autoimmune disease.